4 employees
Ebb Therapeutics develops regional cerebral thermal therapy (RCTT) device for use in insomnia and sleep disorders.
2008
$38M
from 3 investors over 3 rounds
Ebb Therapeutics raised $38M on January 5, 2017
Investors: KKR & Co. Inc., Versant Ventures and Partner Ventures